Mode VC
Massachusetts

Omega Funds

Omega Funds, based in Massachusetts, backs life sciences companies at Seed, Series A, and Series B, can lead rounds, and writes checks from $10 million to over $30 million.

Website LinkedInPitch pageTeam page
Entry stageSeed, Series A, Series B
Check size$10M to $30M+
Leads roundsYes
FocusLife sciences
Latest fund$470.0M Fund VIII
Investing team11 peopleNo activity since Sep

Who you would pitch at Omega Funds

11 people on the investing team, 1 of them partners who can make the call. Partners are listed first.

Francesco Draetta
Francesco DraettaManaging DirectorHe focuses on early-stage therapeutic investments and co-leads fundraising activities.
Bernard Davitian
Bernard DavitianInvestorHe has extensive pharma and biotech experience, serving on boards and previously at Sanofi Ventures.
Claudio Nessi
Claudio NessiInvestorHe previously held roles at NeoMed Management and Genevest Consulting Group, with over 20 years in healthcare venture capital.
Deirdre Cunnane
Deirdre CunnaneInvestorShe previously held legal and financial roles at Catabasis Pharmaceuticals, Advanced Technology Ventures, and Lightstone Ventures.
Eric Cooper
Eric CooperInvestor
Kurt Kongtong-Gallagher
Kurt Kongtong-GallagherInvestorHe previously held science and business development fellowships at several organizations, and holds a PhD in Immunology from Harvard University.
Michelle Doig
Michelle DoigInvestorShe has over 20 years of experience in life sciences finance and M&A, and serves on multiple boards.
Noelle Hutchins
Noelle HutchinsInvestorFocus: private investments in oncology and inflammatory disorders.
Otello Stampacchia
Otello StampacchiaInvestorHe has over two decades of experience, including roles at AlpInvest Partners, Lombard Odier, Goldman Sachs, and Index Securities.
Saoussen Ben Halima
Saoussen Ben HalimaInvestorFocus: healthcare venture investments.
Vincent Ossipow
Vincent OssipowInvestorHe previously worked at NeoMed Management, Sectoral Asset Management, and Pictet Bank.

Work here and something is wrong? Ask for a correction.

Writes $10M to $30M+ checks. Its smallest check is larger than 97% of firms in the atlas.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.

Before you pitch

Ownership target7-10%
How to reach them[email protected]

Notable investments

Dynavax

In their words

People. Products. Platforms. — Omega FundsWe aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.omegafunds.com
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when Omega Funds is active

One email when this firm shows new activity. Nothing else.

Firms like Omega Funds

MVM Life Science Partners$10M to $30M+
DCVC$10M to $30M+ · active Oct 8
RA Capital Management$3M to $30M+
Apple Tree Partners$10M to $30M+
HealthQuest Capital$10M to $30M+
Signet Healthcare Partners$10M to $30M+

On these lists

Seed life sciences investors in Massachusetts27Series A life sciences investors in Massachusetts22Series B life sciences investors in Massachusetts11Seed investors in United States2836Series A investors in United States1790Series B investors in United States563Seed life sciences investors186Series A life sciences investors167

Questions

What stage does Omega Funds invest in?

Omega Funds reports entry at seed, series a, series b.

How much does Omega Funds invest?

Omega Funds reports checks of $10M to $30M+.

Does Omega Funds lead rounds?

Yes. Omega Funds says it can lead.

Who are the partners at Omega Funds?

Francesco Draetta (Managing Director).

Is Omega Funds active right now?

No recent activity since September 2026.

Work at Omega Funds? Claim or correct this profile.